Abstract |
The purpose of this study was to determine the diagnostic test characteristics of serum neuregulin-1β (NRG-1β) for the detection of acute coronary syndrome (ACS). We recruited emergency department patients presenting with signs and symptoms prompting an evaluation for ACS. Serum troponin and neuregulin-1β levels were compared between those who had a final discharge diagnosis of myocardial infarction ( STEMI and NSTEMI) and those who did not, as well as those who more broadly had a final discharge diagnosis of ACS ( STEMI, NSTEMI, and unstable angina). Of 319 study participants, 11% had evidence of myocardial infarction, and 19.7% had a final diagnosis of ACS. Patients with MI had median neuregulin levels of 0.16 ng/mL (IQR [0.16-24.54]). Compared to the median of those without MI, 1.46 ng/mL (IQR [0.16-15.02]), there was no significant difference in the distribution of results (P = 0.63). Median neuregulin levels for patients with ACS were 0.65 ng/mL (IQR [0.16-24.54]). There was no statistical significance compared to those without ACS who had a median of 1.40 ng/mL (IQR [0.16-14.19]) (P = 0.95). Neuregulin did not perform successfully as a biomarker for acute MI or ACS in the emergency department.
|
Authors | Maame Yaa A B Yiadom, Jeremy Greenberg, Holly M Smith, Douglas B Sawyer, Dandan Liu, Jahred Carlise, Laura Tortora, Alan B Storrow |
Journal | Disease markers
(Dis Markers)
Vol. 2016
Pg. 8025271
( 2016)
ISSN: 1875-8630 [Electronic] United States |
PMID | 27110055
(Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- NRG1 protein, human
- Neuregulin-1
- Protein Isoforms
- Serotonin
|
Topics |
- Acute Coronary Syndrome
(diagnosis, metabolism)
- Aged
- Early Diagnosis
- Emergency Service, Hospital
- Female
- Humans
- Male
- Middle Aged
- Myocardial Infarction
(diagnosis, metabolism)
- Neuregulin-1
(blood)
- Pilot Projects
- Protein Isoforms
(blood)
- Serotonin
(blood)
|